CDKC-1 Antibody

What is CDKC-1 and what cellular functions does it have in plants?

CDKC-1 is a cyclin-dependent kinase characterized by a PITAIRE motif in its amino acid sequence, distinguishing it from cell cycle-regulating CDKs that contain PSTAIRE motifs. CDKC-1 functions primarily as a transcriptional regulator rather than a direct cell cycle controller.

Key functions include:

• Phosphorylation of the carboxy-terminal domain (CTD) of RNA polymerase II, specifically at position 5 of the YSPTSPS heptapeptide repeat

• Formation of an active kinase complex with CYCLINT (CYCT) proteins that localizes to the nucleus

• Positive regulation of transcription in plants, functioning similarly to human CDK9/cyclin T complex (P-TEFb)

• Involvement in immune gene expression pathways as part of signaling convergence downstream of multiple immune receptors

• Participation in circadian rhythm regulation alongside CDKC-2

In developmental contexts, such as in tomato, CDKC-1 transcripts are highly expressed during the cell division phase of fruit development and decrease during the cell expansion phase, suggesting temporal regulation of its activity .

What applications are CDKC-1 antibodies typically used for?

CDKC-1 antibodies serve multiple research applications:

• Western Blot (WB): Detection of CDKC-1 protein expression in plant tissue lysates or cell extracts with typical dilutions of 1:1000-1:4000

• ELISA: Quantitative detection of CDKC-1 in plant samples

• Immunoprecipitation (IP): Isolation of CDKC-1 and its interacting partners

• Immunohistochemistry: Visualization of tissue-specific expression patterns

Methodological considerations:

• For Western blots, blocking with 5% non-fat dry milk in TBST is recommended

• Always include appropriate positive controls (recombinant CDKC-1 protein) and negative controls (pre-immune serum)

• When studying phosphorylation events, include phosphatase inhibitors in extraction buffers

• Validate antibody specificity using CDKC-1 knockout or RNAi plant lines

What species reactivity do commercially available CDKC-1 antibodies demonstrate?

Commercial CDKC-1 antibodies are designed for plant research with specific reactivity profiles:

Cross-reactivity with CDKC-1 homologs in other plant species may occur due to sequence conservation, but experimental validation is required. When selecting antibodies for new plant species, sequence alignment of the immunogen region with your target species' CDKC-1 can help predict potential cross-reactivity.

How do CDKC-1 and CDKC-2 differ in their functions and expression patterns?

While CDKC-1 and CDKC-2 share structural similarities, they demonstrate functional differences:

Functional distinctions:

• Simultaneous knockdown of both CDKC-1 and CDKC-2 (via RNAi) produces longer circadian periods (2-5 hours) than cdkc-2 single mutations, suggesting both overlapping and distinct functions

• CDKC-2 appears to have a more prominent role in circadian rhythm maintenance, with single mutants showing period lengthening effects

• Both kinases are potentially involved in RNA polymerase II CTD phosphorylation and are targets of inhibitors like BML-259

Experimental approaches to distinguish their roles:

• Use isoform-specific RNAi constructs to selectively knock down each gene

• Develop phospho-specific antibodies that distinguish between the activation states of each kinase

• Perform complementation studies with one kinase in the background of the other's mutation

• Design chimeric proteins to identify which domains confer specific functions

What is the relationship between CDKC-1 and RNA polymerase II phosphorylation?

CDKC-1 plays a crucial role in transcriptional regulation through specific phosphorylation of RNA polymerase II:

• CDKC-1 forms a complex with CYCT-1 that phosphorylates the carboxy-terminal domain (CTD) of RNA polymerase II's largest subunit

• The target is the YSPTSPS heptapeptide repeat domain, with specific phosphorylation at Ser5

• Mutation of Ser to Ala at position 5 within the heptapeptide repeat abolishes substrate phosphorylation by the CDKC-1 kinase complex, confirming specificity

• This phosphorylation event is critical for promoting transcriptional elongation

Experimental methods to study this relationship:

• In vitro kinase assays with recombinant CDKC-1 and CTD substrates

• Use of phospho-specific antibodies against Ser5-phosphorylated CTD

• ChIP-seq to identify genome-wide binding patterns of differently phosphorylated RNA polymerase II forms

• Transcriptome analysis in CDKC-1 mutant/RNAi plants to identify affected gene sets

What are the optimal Western blot conditions for detecting CDKC-1 in plant samples?

For reliable detection of CDKC-1 in plant samples:

Sample preparation:

• Extract proteins using buffer containing protease inhibitors (and phosphatase inhibitors if studying phosphorylation status)

• For plant tissues, use specialized extraction buffers containing agents to remove interfering compounds (phenolics, polysaccharides)

• Standardize protein loading (20-50 μg total protein per lane)

SDS-PAGE and transfer:

• Use 10-12% polyacrylamide gels for optimal resolution

• Transfer to PVDF or nitrocellulose membranes at 100V for 1 hour or 30V overnight at 4°C

Blocking and antibody incubation:

• Block with 5% non-fat dry milk in TBST for 1 hour at room temperature

• Dilute primary CDKC-1 antibody 1:1000 to 1:4000 in blocking buffer

• Incubate overnight at 4°C with gentle agitation

• Wash 3-5 times with TBST

• Incubate with appropriate HRP-conjugated secondary antibody (typically anti-rabbit IgG)

• Develop using ECL or other chemiluminescent detection system

Troubleshooting:

• High background: Try alternative blocking agents (BSA) or increase washing steps

• Weak signal: Increase antibody concentration, extend incubation time, or use enhanced detection systems

• Multiple bands: Validate with recombinant protein control and consider using more stringent washing conditions

How does the CDKC-1-CYCLINT;1 kinase complex regulate transcription at the molecular level?

The CDKC-1-CYCLINT;1 complex serves as a key regulator of transcription through specific molecular mechanisms:

• The complex forms an active heterodimeric kinase that localizes to the nucleus and phosphorylates the CTD of RNA polymerase II

• This phosphorylation promotes transcriptional elongation by enhancing the processivity of RNA polymerase II

• The Medicago CDKC;1-CYCT;1 heterodimer can completely restore transcriptional activity in a HeLa nuclear extract depleted of endogenous CDK9 kinase complexes, demonstrating functional conservation across kingdoms

Current model of molecular action:

• CDKC-1 associates with CYCLINT;1 to form an active kinase complex

• The complex is recruited to transcription initiation sites

• Phosphorylation of Ser5 in the RNA polymerase II CTD heptapeptide repeat occurs

• This phosphorylation facilitates the transition from transcription initiation to elongation

• Additional factors are recruited based on the phosphorylation pattern

Advanced research approaches:

• Structural analysis of the CDKC-1-CYCLINT;1 complex using cryo-EM or X-ray crystallography

• Identify genome-wide binding sites using ChIP-seq with CDKC-1 antibodies

• In vitro reconstitution of the transcription elongation complex to identify additional regulatory factors

How can CDKC-1 antibodies be used to study plant immune responses?

CDKC-1 plays significant roles in plant immune signaling networks, and antibodies can help elucidate these functions:

• CDKC proteins undergo rapid phosphorylation upon MAMP (microbe-associated molecular pattern) perception

• They are activated by MAP kinase cascades and represent signaling convergence points downstream of multiple immune receptors

• CDKC-mediated RNA polymerase II CTD phosphorylation is critical for orchestrating immune gene expression

Experimental applications:

• Phosphorylation dynamics: Use phospho-specific antibodies to monitor CDKC-1 activation after pathogen treatment

• Protein-protein interactions: Conduct co-immunoprecipitation with CDKC-1 antibodies to identify interaction partners during immune responses

• Chromatin immunoprecipitation: Map CDKC-1 recruitment to defense-related genes using ChIP-seq

• Tissue-specific activation: Use immunohistochemistry to visualize CDKC-1 activation in different cell types during infection

Research design example:
To study CDKC-1's role in MAMP-triggered immunity, treat Arabidopsis seedlings with flg22 or elf18 peptides, collect samples at multiple time points (0, 15, 30, 60, 120 minutes), and analyze CDKC-1 phosphorylation status and association with defense gene promoters using phospho-specific antibodies and ChIP .

What methods can validate the specificity of CDKC-1 antibodies for research applications?

Comprehensive validation of CDKC-1 antibody specificity is essential for reliable research results:

Genetic validation:

• Test antibody reactivity in CDKC-1 knockout or RNAi plant lines (signal should be absent or significantly reduced)

• Use CRISPR-edited plants with epitope-tagged CDKC-1 for confirmation

• Compare signal between wild-type and genetically modified tissues

Biochemical validation:

• Pre-adsorption test: Pre-incubate antibody with recombinant CDKC-1 protein before immunodetection

• Evaluate using recombinant CDKC-1 as positive control and pre-immune serum as negative control

• Test cross-reactivity with related proteins (CDKC-2, other CDKs) using purified proteins

Multiple detection methods:

• Compare results across different applications (Western blot, ELISA, immunoprecipitation)

• Use multiple antibodies targeting different epitopes of CDKC-1

• Validate findings with orthogonal methods (mass spectrometry, activity assays)

How can phospho-specific antibodies be designed to study CDKC-1-mediated phosphorylation events?

Developing phospho-specific antibodies requires systematic approach:

Phospho-epitope identification:

• Use mass spectrometry to identify CDKC-1 phosphorylation sites or those on its substrates

• Focus on Ser5 in the YSPTSPS heptapeptide of RNA polymerase II CTD, a known CDKC-1 target

• Select unique sequence regions surrounding the phosphorylation site

Peptide design strategy:

• Design phosphopeptides (10-15 amino acids) centered on the phosphorylated residue

• Include a terminal cysteine for conjugation to carrier protein

• Synthesize both phosphorylated and non-phosphorylated versions of the peptide

Antibody production and purification:

• Immunize rabbits with the phosphopeptide conjugated to KLH or other carrier

• Screen antisera against both phosphorylated and non-phosphorylated peptides

• Purify using affinity chromatography with phospho-peptide columns

• Remove cross-reactive antibodies using non-phosphorylated peptide columns

Validation methods:

• Test antibody against samples treated with λ-phosphatase (signal should disappear)

• Use in vitro kinase assays with recombinant CDKC-1 to generate phosphorylated substrates

• Verify specificity using CDKC-1 knockout/RNAi lines

These phospho-specific antibodies would be invaluable for tracking CDKC-1 activity during immune responses, circadian regulation, and other plant signaling networks.

How does CDKC-1 inhibition affect plant circadian rhythm regulation?

Research indicates important connections between CDKC-1 activity and circadian rhythm regulation:

• RNA interference targeting both CDKC-1 and CDKC-2 results in lengthened circadian periods by 2-5 hours compared to control seedlings

• CDKC-2 single mutants show period lengthening, suggesting overlapping but distinct roles for CDKC-1 and CDKC-2

• The inhibitor BML-259 targets both CDKC-1 and CDKC-2, with enhanced sensitivity in cdkc-2 mutants or CDKC-1/CDKC-2 RNAi lines

Experimental approaches for investigation:

• Monitor circadian reporter gene expression (e.g., CCA1::LUC) in plants with altered CDKC-1 levels

• Track CDKC-1 protein and phosphorylation levels across the circadian cycle using specific antibodies

• Perform ChIP-seq to identify circadian-regulated genes directly targeted by CDKC-1

• Use pharmacological approaches with specific CDKC inhibitors like BML-259

• Analyze genetic interactions between CDKC-1 and core clock components

Technical considerations:

• Sample collection should occur at multiple time points across 24-48 hours under constant light or dark conditions

• Compare wild-type plants with clock mutants and CDKC-1/CDKC-2 single and double mutants

• Analyze both transcriptional and post-translational regulation

This research area represents an exciting frontier for understanding how transcriptional regulation through CDKC-1-mediated phosphorylation contributes to circadian clock function in plants.

Commercial CDKC-1 Antibody Specifications

Recommended Dilutions for Different Applications

CDKC-1 Expression During Plant Development Stages

This information is derived from expression studies in tomato (Lyces;CDKC;1) .

CDKC-1 and Related Proteins Interaction Partners

Common Problems and Solutions in Western Blot Applications

Optimizing CDKC-1 Detection in Plant Tissues

• Tissue selection: Young, actively growing tissues typically express higher levels of CDKC-1

• Extraction buffer optimization:

  • Include 1% PVPP to remove phenolic compounds

  • Add DTT (1-5 mM) to prevent oxidation

  • Use complete protease inhibitor cocktail

  • Include phosphatase inhibitors when studying phosphorylation events

• Sample processing:

  • Extract proteins at 4°C

  • Clarify extracts by centrifugation at 14,000 × g for 10 minutes

  • Quantify protein concentration using Bradford or BCA assay

• Control samples:

  • Include recombinant CDKC-1 protein as positive control

  • Use pre-immune serum as negative control